We haven't figured out how to teleport patients into medical offices. But telemedicine technologies link patients and clinicians in ways Ray Bradbury would admire.
7 of 12
At-home patient monitoring is one of the most common uses of telemedicine. VitalPoint, from CJPS Medical Systems, is a standalone, single unit, 4.5-lb device that can monitor multiple vital signs, including blood pressure, blood oxygen saturation, pulse rate, weight, glucose level, prothrombin time and ratios, temperature, fluid status, and electrocardiogram data, and provide the caregiver with the ability to remotely monitor patients' conditions using their laptop or cellphone. The physiological data finds its way into the unit, pictured here, through peripheral medical devices--some wired and some wireless.
Features include a large touch screen and design that's easy for patients, from pediatric to geriatric, to use. The device also provides users with audible reminders of scheduled activities; clinicians' messages; and detailed illustrations and clear voice prompts that guide them through vital signs measurement activities and non-emergency symptom reporting. The product can connect via phone lines if patients don't have Internet access in their homes.
InformationWeek Elite 100Our data shows these innovators using digital technology in two key areas: providing better products and cutting costs. Almost half of them expect to introduce a new IT-led product this year, and 46% are using technology to make business processes more efficient.
The UC Infrastructure TrapWorries about subpar networks tanking unified communications programs could be valid: Thirty-one percent of respondents have rolled capabilities out to less than 10% of users vs. 21% delivering UC to 76% or more. Is low uptake a result of strained infrastructures delivering poor performance?
InformationWeek Tech Digest, Nov. 10, 2014Just 30% of respondents to our new survey say their companies are very or extremely effective at identifying critical data and analyzing it to make decisions, down from 42% in 2013. What gives?